Depressive symptom deterioration among predominantly Hispanic diabetes patients in safety net care

Kathleen Ell, Wayne Katon, Pey-Jiuan Lee, Suad Kapetanovic, Jeffrey Guterman, Bin Xie, Chih-Ping Chou, Kathleen Ell, Wayne Katon, Pey-Jiuan Lee, Suad Kapetanovic, Jeffrey Guterman, Bin Xie, Chih-Ping Chou

Abstract

Objective: This study examines clinical predictors of symptom deterioration (relapse/recurrence) at the completion of a clinical intervention trial of depressed, low-income, predominantly Hispanic diabetes patients who were randomized to socio-culturally adapted collaborative depression treatment or usual care and who no longer met clinically significant depression criteria at 12 months post-trial baseline.

Methods: A sub-cohort of 193 diabetes patients with major depression symptoms at baseline, who were randomized to a 12-month collaborative care intervention (INT) (problem-solving therapy and/or pharmacotherapy, telephone symptom monitoring/relapse prevention, behavioral activation and patient navigation support) or enhanced usual care (EUC), and who did not meet major depression criteria at 12 months were subsequently observed over 18 to 24 months.

Results: Post-trial depression symptom deterioration was similar between INT (35.2%) and EUC (35.3%) groups. Among the combined groups, significant predictors of symptom deterioration were baseline history of previous depression and/or dysthymia (odds ratio [OR] = 2.66), 12-month PHQ-9 score (OR = 1.22), antidepressant treatment receipt during the initial 12-months (OR = 2.38), 12-month diabetes symptoms (OR = 2.27), and new ICD-9 medical diagnoses in the initial 12 months (OR = 1.11) (R2 = 27%; max-rescaled R2 = 37%; likelihood ratio test, χ2 = 59.79, df = 5, P < 0.0001).

Conclusions: Among predominantly Hispanic diabetes patients in community safety net primary care clinics whose depression had improved over 1 year, more than one-third experienced symptom deterioration over the following year. A primary care management depression care protocol that includes ongoing depression symptom monitoring, antidepressant adherence, and diabetes and co-morbid illness monitoring plus depression medication adjustment and behavioral activation may reduce and/or effectively treat depression symptom deterioration.

Trial registration: ClinicalTrials.gov NCT00709150.

Copyright © 2012 The Academy of Psychosomatic Medicine. All rights reserved.

Figures

Figure 1
Figure 1
Sample Selection

References

    1. Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev. 2007;27(8):959–985.
    1. Richards D. Prevalence and clinical course of depression: A review. Clin Psychol Rev. 2011;31(7):1117–1125.
    1. Li C, Ford ES, Strine TW, Mokdad AH. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care. 2008;31(1):105–107.
    1. Lustman P, Griffith LS, Freedland KE, Clouse RE. The course of major depression in diabetes. Gen Hosp Psychiatry. 1997;19(2):138–143.
    1. Katon W, Rutter C, Ludman EJ, Von Korff M, Lin E, Simon G, et al. A Randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry. 2001;58(3):241–247.
    1. Katon WJ. The comorbidity of diabetes mellitus and depression. Am J Med. 2008;121(11 Suppl 2):S8–15.
    1. Lin EHB, Rutter CR, Katon W, Heckbert SR, Ciechanowski P, Oliver MM, et al. Depression and advanced complications of diabetes: A prospective cohort study. Diabetes Care. 2010;33(2):264–269.
    1. Beshai S, Dobson KS, Bockting CL, Quigley L. Relapse and recurrence prevention in depression: current research and future prospects. Clin Psychol Rev. 2011;31(8):1349–1360.
    1. Monroe SM, Harkness KL. Recurrence in major depression: a conceptual analysis. Psychol Rev. 2011;118(4):655–674.
    1. Riihimäki KA, Vuorilehto MS, Melartin TK, Isometsä ET. Five-year outcome of major depressive disorder in primary health care. Psychol Med. 2011 doi.10.1017/S0033291711002303.
    1. Culpepper L. Why do you need to move beyond first-line therapy for major depression? J Clin Psychiatry. 2010;71(Suppl 1):4–9.
    1. Segal ZV, Bieling P, Young T, MacQueen G, Cooke R, Martin L, et al. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Arch Gen Psychiatry. 2010;67(12):1256–1264.
    1. Bao Y, Alexopoulos GS, Casalino LP, Ten Have TR, Donohue JM, Post EP, et al. Collaborative depression care management and disparities in depression treatment and outcomes. Arch Gen Psychiatry. 2011;68(6):627–636.
    1. Osborn CY, Trott HW, Buchowski MS, Patel KA, Kirby LD, Hargreaves MK, et al. Racial disparities in the treatment of depression in low-income persons with diabetes. Diabetes Care. 2010;33(5):1050–1054.
    1. Lanting LC, Joung IM, Mackenbach JP, Lamberts SW, Bootsma AH. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients. Diabetes Care. 2005;28(9):2280–2288.
    1. Gross R, Olfson M, Gameroff MJ, Carasquillo O, Shea S, Feder A, et al. Depression and glycemic control in Hispanic primary care patients with diabetes. J Gen Intern Med. 2005;20(5):460–466.
    1. Alegría M, Chatterji P, Wells K, Cao Z, Chen CN, Takeuchi D, et al. Disparity in depression treatment among racial and ethnic minority populations in the United States. Psychiatr Serv. 2008;59(11):1264–1272.
    1. Interian A, Ang A, Gara MA, Rodriguez MA, Vega WA. The long-term trajectory of depression among Latinos in primary care and its relationship to depression care disparities. Gen Hosp Psych. 2011;33(2):94–101.
    1. Ell K, Katon W, Xie B, Lee PJ, Kapetanovic S, Guterman J, et al. One year post collaborative depression care trial outcomes among predominantly Hispanic diabetes safety net patients. Gen Hosp Psychiatry. 2011;33(5):436–442.
    1. Ell K, Katon W, Xie B, Lee PJ, Kapetanovic S, Guterman J, et al. Collaborative care management of major depression among low-income, predominantly Hispanics with diabetes: a randomized controlled trial. Diabetes Care. 2010;33(4):706–713.
    1. Ell K, Katon W, Cabassa LJ, Xie B, Lee PJ, Kapetanovic S, et al. Depression and diabetes among low-income Hispanics: design elements of a socio-culturally adapted collaborative care model randomized controlled trial. International J Psychiatry Med. 2009;39(2):113–132.
    1. Cabassa LJ, Hansen MC, Palinkas LA, Ell K. Azúcar y Nervios: explanatory models and treatment experiences of Hispanics with diabetes and depression. Soc Sci Med. 2008;66(12):2413–2414.
    1. Hay JW, Katon WJ, Ell K, Lee PJ, Guterman J. Cost effectiveness analyses of collaborative care management of major depression among low-income, predominantly Hispanics with diabetes. Value in Health. in press.
    1. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry. 1974;7(0):79–110.
    1. Wittkampf KA, Naeije L, Schene AH, Huyser J, van Weert HC. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psychiatry. 2007;29(5):388–395.
    1. Huang FY, Chung H, Kroenke K, Delucchi KL, Spitzer RL. Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med. 2006;21(6):547–552.
    1. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13(3):595–605.
    1. Sullivan M, Katon W, Russo J, Dobie R, Sakai C. A randomized trial of nortriptyline for severe chronic tinnitus: effects on depression, disability, and tinnitus symptoms. Arch Intern Med. 1993;153(19):2251–2259.
    1. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851–859.
    1. Toobert DJ, Hampson SE, Russell E. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–950.
    1. Whitty P, Steen N, Eccles M, McColl E, Hewison J, Meadows K, et al. A new self-completion outcome measure for diabetes: Is it responsive to change? Qual Life Res. 1997;6(5):407–413.
    1. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299(23):2751–2750.
    1. Katon W, Russo J, Lin EH, Heckbert SR, Ciechanowski P, Ludman EJ, et al. Depression and diabetes: factors associated with major depression at 5-year follow-up. Psychosomatics. 2009;50(6):570–579.
    1. Vittengl JR, Clark LA, Jarrett RB. Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression. J Affect Disord. 2009;112(1–3):135–143.
    1. Dobson KS, Hollon SD, Dimidjian S, Schmaling KB, Kohlenberg RJ, Gallop RJ, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol. 2008;76(3):468–477.
    1. Katon WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611–2620.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe